![](/img/cover-not-exists.png)
Comparative analysis of natalizumab versus fingolimod as second-line treatment in relapsing–remitting multiple sclerosis
Lorscheider, Johannes, Benkert, Pascal, Lienert, Carmen, Hänni, Peter, Derfuss, Tobias, Kuhle, Jens, Kappos, Ludwig, Yaldizli, ÖzgürLanguage:
english
Journal:
Multiple Sclerosis Journal
DOI:
10.1177/1352458518768433
Date:
April, 2018
File:
PDF, 258 KB
english, 2018